InvestorInformation
Latest Annoucements
-
Disclosure of material event – Acquisition
-
Disclosure of material event
-
Disclosure of material event – Audio recording of Investors/Analysts meet
-
Q4 FY22 Investor Presentation
-
Recommendation of Final Dividend for FY 2021-22
-
Q4 FY22 Press Release
-
Q4 FY22 Results Sheet
-
Disclosure of material event – Update on Assignment of Trademark for Azmarda® indicated for heart failure patients with reduced ejection fraction (HfrEF) from Novartis AG, Switzerland for India
-
Assignment of Trademark for Azmarda® from Novartis AG, Switzerland for India
-
Disclosure of material event – Resignation of Director
-
Intimation of record date for Interim Dividend
-
Declaration of Interim Dividend for FY 2021-22
-
Q3 FY22 Press Release
-
Q3 FY22 Investor Presentation
-
Q3 FY22 Results Sheet
-
Schedule of Investors /Analysts’ call with Management on 15.02.2022 and Registration Log-in details.
-
Investor presentation in relation to Acquisition of Brands and Related Assets from Sanzyme Private Limited- 27.01.2022
-
Disclosure of material event – Resignation of Director
-
Press Release in relation to Acquisition of Brands and Related Assets from Sanzyme Private Limited
-
Disclosure of material event – Acquisition of Brands and Related Assets from Sanzyme Private Limited
-
Schedule of Investors / Analysts’ call with Management on 27.01.2022 and Registration Log-in details for the same
IR & Shareholders Contact
For Shareholders:
Company Secretary
Cnergy IT Park, Unit A2, 3rd floor,
Appa Saheb Marathe Marg,
Prabhadevi, Mumbai 400 025.
India.
Tel No. 91-22-2439 5200 / 2439 5500
Fax No. 91-22-2431 5331 / 2431 5334
Email: investorelations@jbpharma.com
For Transfer/Transmission of Shares:
Datamatics Business Solutions Ltd.
Plot No. B 5, Part B Crosslane,
MIDC, Andheri (East), Mumbai 400 093.
India.
Contact Person: Mr. Satish Patil
Tel No. (022) 6671 2001-06
Fax No. (022) 6671 2011
Email: corpequity@dfssl.com
Nodal Officer for the Purpose of
Coordination with IEPF Authority:
Company Secretary
Cnergy IT Park, Unit A2, 3rd floor,
Appa Saheb Marathe Marg, Prabhadevi,
Mumbai 400 025.
India.
Tel No. 91-22-2439 5200 / 2439 5500
Fax No. 91-22-2431 5331 / 2431 5334
Email: investorelations@jbpharma.com